教育背景：

2018.9-2022.6 贵州大学，应用化学，理学学士

2022.9-2025.6 江西科技师范大学，分析化学，理学硕士

在校成果：

[1] An Y, Lv X, Xu S, et al. Pyrimidine-based dual-target inhibitors targeting epidermal growth factor receptor for overcoming drug resistance in cancer therapy(2006-present)[J]. European Journal of Medicinal Chemistry, 2025, 286: 117268. (IF=6.0, SCI)

[2] Huang X¹, Xu S¹, An Y, et al. Revealing 5-(3,5-difluorobenzyl)-1H-indazole as the active pharmacophore of ALK/ROS1 dual inhibitors through theoretical calculations and biological activity evaluations[J]. Bioorganic Chemistry, 2025, 154: 108014.(IF=4.5, SCI)

[3] Wang L, An Y, Wei X, et al. In silico screening combined with bioactivity evaluation to identify AMI-1 as a novel anticancer compound by targeting AXL[J]. Journal of Biomolecular Structure and Dynamics, 2024, 42(15): 7686-7698. (IF=2.7, SCI)

[4] Xu S¹, Huang X¹, An Y, et al. In silico screening applied in drug discovery: T001-10026247 as a novel fourth-generation EGFR inhibitor[J]. New Journal of Chemistry, 2023, 47(44): 20405-20416. (IF=2.7, SCI)

荣誉奖励：

2022-2023学年江西省研究生学业奖学金

2023-2024学年江西省研究生学业奖学金

2024-2025学年江西省研究生学业奖学金

2022-2023学年江西科技师范大学“优秀研究生”

第九届江西省“互联网+”大学生创新创业大赛，省级银奖3项

联系方式：

ayf1015@163.com，18198321164